SurModics bolsters IVD business with CodeLink microarray tech

In a bid to strengthen its in vitro diagnostics offering, surface modification and drug delivery firm SurModics has purchased the CodeLink activated slide microarray business from GE Healthcare.

In a bid to strengthen its in vitro diagnostics offering, surface modification and drug delivery firm SurModics has purchased the CodeLink activated slide microarray business from GE Healthcare.

Eden Prairie, Minnesota-based SurModics originally began manufacturing surface chemistry technology for the microarray sector in 1999 and marketed the technology...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Archive

More from Medtech Insight